Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Cost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Entera Bio (ENTX) Shares Outstanding (2018 - 2025)

Entera Bio has reported Shares Outstanding over the past 8 years, most recently at $46.2 million for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding rose 18.9% year-over-year to $46.2 million, compared with a TTM value of $46.2 million through Dec 2025, up 18.9%, and an annual FY2025 reading of $46.2 million, up 18.9% over the prior year.
  • Shares Outstanding came in at $46.2 million for Q4 2025, up from $45.7 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $46.2 million in Q4 2025 to a low of $23.8 million in Q1 2021.
  • Median Shares Outstanding over the past 5 years was $28.8 million (2023), compared with a mean of $33.8 million.
  • The sharpest move saw Shares Outstanding surged 36.79% in 2021, then rose 0.01% in 2023.
  • Over 5 years, Shares Outstanding stood at $28.8 million in 2021, then rose by 0.02% to $28.8 million in 2022, then increased by 23.14% to $35.5 million in 2023, then grew by 9.47% to $38.8 million in 2024, then increased by 18.9% to $46.2 million in 2025.
  • Per Business Quant, the three most recent readings for ENTX's Shares Outstanding are $46.2 million (Q4 2025), $45.7 million (Q3 2025), and $45.5 million (Q2 2025).